Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives

Meitao Duan,Ahmed Mahal,Anas Alkouri,Chen Wang,Zhiqiang Zhang,Jungang Ren,Ahmad J. Obaidullah

DOI: https://doi.org/10.3390/molecules29133010

IF: 4.6

2024-06-26

Molecules

Abstract:Cancer is one of the deadliest diseases to humanity. There is significant progress in treating this disease, but developing some drugs that can fight this disease remains a challenge in the field of medical research. Thirteen new 1,2,3-triazole linked tetrahydrocurcumin derivatives were synthesized by click reaction, including a 1,3-dipolar cycloaddition reaction of tetrahydrocurcumin baring mono-alkyne with azides in good yields, and their in vitro anticancer activity against four cancer cell lines, including human cervical carcinoma (HeLa), human lung adenocarcinoma (A549), human hepatoma carcinoma (HepG2), and human colon carcinoma (HCT-116) were investigated using MTT(3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetraz-olium bromide) assay. The newly synthesized compounds had their structures identified using NMR HRMS and IR techniques. Some of prepared compounds, including compounds 4g and 4k, showed potent cytotoxic activity against four cancer cell lines compared to the positive control of cisplatin and tetrahydrocurcumin. Compound 4g exhibited anticancer activity with a IC50 value of 1.09 ± 0.17 μM against human colon carcinoma HCT-116 and 45.16 ± 0.92 μM against A549 cell lines compared to the positive controls of tetrahydrocurcumin and cisplatin. Moreover, further biological examination in HCT-116 cells showed that compound 4g can arrest the cell cycle at the G1 phase. A docking study revealed that the potential mechanism by which 4g exerts its anti-colon cancer effect may be through inhabiting the binding of APC–Asef. Compound 4g can be used as a promising lead for further exploration of potential anticancer agents.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new potential anti - cancer drugs. Specifically, the authors synthesized 13 new 1,2,3 - triazole - linked tetrahydrocurcumin derivatives and evaluated their in vitro anti - cancer activities against four human cancer cell lines (human cervical cancer cell HeLa, human lung adenocarcinoma cell A549, human liver cancer cell HepG2 and human colon cancer cell HCT - 116). The cytotoxicity of these compounds was determined by the MTT method and compared with the positive control drugs cisplatin and tetrahydrocurcumin. In addition, further biological studies, including cell cycle arrest analysis and molecular docking studies, were carried out on one of the more active compounds, 4g, to explore its possible anti - colon cancer mechanisms. ### Main research contents: 1. **Synthesis methods**: - Thirteen new 1,2,3 - triazole - linked tetrahydrocurcumin derivatives were synthesized by click reaction, that is, 1,3 - dipolar cycloaddition reaction. - The newly synthesized compounds were structurally identified using nuclear magnetic resonance (NMR), high - resolution mass spectrometry (HRMS) and infrared spectroscopy (IR) techniques. 2. **Anti - cancer activity evaluation**: - The in vitro anti - cancer activities of these compounds against four human cancer cell lines were evaluated by the MTT method. - The results showed that some compounds (such as 4g and 4k) exhibited significant cytotoxicity. In particular, the IC50 value of compound 4g in the HCT - 116 cell line was 1.09 ± 0.17 µM, which was better than the positive control drugs cisplatin and tetrahydrocurcumin. 3. **Cell cycle arrest analysis**: - Cell cycle analysis of compound 4g in the HCT - 116 cell line was carried out, and it was found that it could arrest the cell cycle in the G1 phase. 4. **Molecular docking study**: - The interaction between compound 4g and the APC - Asef protein complex was studied by molecular docking technology, and it was found that 4g may play its anti - colon cancer role by inhibiting the binding of APC - Asef. ### Research significance: - This study provides potential candidate compounds for the development of new anti - cancer drugs. In particular, compound 4g shows strong anti - cancer activity and a clear mechanism of action. - Through molecular docking studies, it lays the foundation for further exploration of the development of these compounds as potential anti - cancer drugs.

Synthesis, Anticancer Activity, and Molecular Docking of New 1,2,3-Triazole Linked Tetrahydrocurcumin Derivatives

Synthesis and Antitumor Activity Study of Nitrogen-Containing Curcumin Derivatives

Synthesis and antitumor activity of new tetrahydrocurcumin derivatives via click reaction

Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues

Schiff Bases of Tetrahydrocurcumin as Potential Anticancer Agents

Design and Click Synthesis of Novel 1- Substituted-4-(3,4-Dimethoxyphenyl)-1H-1,2,3-Triazole Hybrids for Anticancer Evaluation and Molecular Docking

Design, Synthesis, Cytotoxic Evaluation, and Molecular Docking of New Alkyl Triphenylphosphonium Curcumin Derivatives

Synthesis, Molecular Docking and Antitumor Activity of New Dithiazoles

Design of New Benzo[h]chromene Derivatives: Antitumor Activities and Structure-Activity Relationships of the 2,3-Positions and Fused Rings at the 2,3-Positions

Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives

Design, Synthesis, and Antitumor Evaluation of Novel Mono-Carbonyl Curcumin Analogs in Hepatocellular Carcinoma Cell

New 1,2,3-Triazole-Containing Hybrids as Antitumor Candidates: Design, Click Reaction Synthesis, DFT Calculations, and Molecular Docking Study

Synthesis, Anticancer Activity, and Preliminary Pharmacokinetic Evaluation of 4,4-Disubstituted Curcuminoid 2,2-bis(Hydroxymethyl)Propionate Derivatives

Synthesis and Cancer Cell Cytotoxicity of 6‐, 7‐, or 8‐Substituted 2‐(Hetero)aryl‐4‐(4‐(Hetero)aryl‐2‐Oxobut‐3‐en‐1‐Ylidene)Benzothiazepanes

Synthesis and molecular docking of some new thiazolidinone and thiadiazole derivatives as anticancer agents

Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2

Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs

Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents

Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents

Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer

Synthesis, characterization, quantum mechanical calculations and biomedical docking studies on curcumin analogs: 2, 6-(Difurfurylidene) cyclohexanone and 2, 6 - Bis (2,6-Dichloro Benzylidene) Cyclohexanone